1.
END-OF-LIFE MEDICAL TREATMENT PREFERENCE DISCUSSIONS AND SURROGATE DECISION-MAKER APPOINTMENTS: EVIDENCE FROM ITALY, SPAIN, BELGIUM AND THE NETHERLANDS
2.
3.
4.
5.
6.
7.
8.
9.
End-of-life decisions: a cross-national study of treatment preference discussions and surrogate decision-maker appointments